All use outside of clinical trials is experimental and unregulated
If patients do not achieve glycemic control with metformin alone, duplex treatment should be used
Another key area of interest is its potential to reduce inflammatory signaling , particularly through pathways associated with NF-kappaB modulation
The first patient, treated in 1906, was a 50 year old dying man who had just had his toe amputated due to gangrene from diabetes and was in a diabetic coma
How easy it is to take the medicine
Canelas AB, ten Pierick A, Ras C, Seifar RM, van Dam JC, van Gulik WM, Heijnen JJ